Tag: health policy analysis

ISPOR Announces Plenary Sessions and Speakers For 22nd Annual International Meeting

Conference to Focus on Timely Theme of Evidence and Value in a Time of Social and Policy Change Princeton, NJ—March 6, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 22nd Annual International

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , ,

THE FOURTH HURDLE – CAN IT BE SIMPLIFIED?

Melbourne, Australia – While regulatory systems are well established within Asia-Pacific countries, formalised health technology assessment (HTA) based reimbursement systems are relatively new, yet rapidly evolving. Closer understanding of the different reimbursement processes within Asia-Pacific can allow for best-practice cross-pollination, leading

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , , ,

HEALTH CARE DECISION MAKERS OPEN FOR PUBLIC AND PATIENT INVOLVEMENT IN COVERAGE DECISIONS

Brussels, Belgium – In a democratic system, politicians are elected to make decisions regarding health care priorities. In deliberation-driven systems, such as in Belgium, coverage decisions are based on the outcomes of a deliberation amongst stakeholders (including public authorities, providers,

Posted in Health Policy Analyses, Value in Health Tagged with: , , ,

IDENTIFYING THE FACTORS THAT ENHANCE POSITIVE DRUG REIMBURSEMENT RECOMMENDATION IN SCOTLAND

Rotterdam, The Netherlands – Given limited health care resources and rising expenditures on pharmaceuticals, policy makers are increasingly confronted with the challenging task to improve patient outcomes and reimburse new pharmaceutical interventions. Arguably, Scotland is often one of the first

Posted in Announcements, Health Policy Analyses, Value in Health Tagged with: , , , , , ,